The Vox Markets Podcast / Greg Madison of Shield Therapeutics discusses the progress of their lead product in the U.S.

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.